results for pembrolizumab as a first-line therapy for advanced urothelial carcinoma
Published 7 years ago • 117 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:58
results for first-line pembrolizumab in advanced urothelial carcinoma
-
2:15
results of a first-line study of pembrolizumab in advanced urothelial cancer
-
3:21
esmo 2020 highlights on pembrolizumab as 1st line therapy for auc: the keynote-361 study
-
2:05
pembrolizumab as second-line therapy for advanced urothelial carcinoma
-
2:41
firstline pembrolizumab for metastatic urothelial cancer
-
58:25
molecular targeted therapies for advanced hcc
-
2:10
initial ev-103 results: enfortumab vedotin plus pembrolizumab for urothelial carcinoma
-
3:37
pembrolizumab plus chemo as firstline therapy for nsclc
-
0:16
imvigor 210 results in metastatic urothelial carcinoma
-
16:37
state of the art lecture - developments in metastatic urothelial cancer
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
1:04
choosing second-line therapy for patients with urothelial carcinoma
-
20:21
targeted therapy for the treatment of advanced metastatic urothelial cancer youtube
-
44:20
systemic therapies for advanced urothelial cancer
-
1:09
keynote-045 – pembrolizumab as second-line treatment in urothelial carcinoma
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
1:34
phase 2 trial of cv301 vaccine plus atezolizumab in advanced urothelial carcinoma
-
19:21
immunotherapy for muscle invasive bladder cancer
-
2:35
keynote-361 and -045: pembrolizumab monotherapy in urothelial carcinoma